20.500.12556/DiRROS-12421 Lung cancer biomarker testing : perspective from Europe A questionnaire on biomarker testing previously used in central European countries was extended and distributed in Western and Central European countries to the pathologists participating at the Pulmonary Pathology Society meeting 26-28 June 2019 in Dubrovnik, Croatia. Each country was represented by one responder. For recent biomarkers the availability and reimbursement of diagnoses of molecular alterations in non-small cell lung carcinoma varies widely between different, also western European, countries. Reimbursement of such assessments varies widely between unavailability and payments by the health care system or even pharmaceutical companies. The support for testing from alternative sources, such as the pharmaceutical industry, is no doubt partly compensating for the lack of public health system support, but it is not a viable or long-term solution. Ideally, a structured access to testing and reimbursement should be the aim in order to provide patients with appropriate therapeutic options. As biomarker enabled therapies deliver a 50% better probability of outcome success, improved and unbiased reimbursement remains a major challenge for the future. lung neoplasms -- diagnosis -- therapy -- Europe lung cancer predictive testing pljučne novotvorbe -- diagnostika -- terapija -- Evropa pljučni rak napovedno testiranje true false true AME Publishing Angleški jezik Ni določen © Translational Lung Cancer Research Neznano 2020-09-21 11:47:52 2020-09-21 11:47:52 2022-08-18 03:37:20 0000-00-00 00:00:00 2020 0 Kitajska 0 Nasl. z nasl. zaslona; Soavtor iz Slovenije: Izidor Kern; Opis vira z dne 11. 9. 2020; str. 887-897 iss. 3 Vol. 9 Jun. 2020 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616-006 2226-4477 28071683 17120003 RAZ_Thunnissen_Erik_i2020.pdf RAZ_Thunnissen_Erik_i2020.pdf 1 08500071FD4E2273A0DACAEECA7E7FDB 40132dc9a1c3f5103d696bed04eb340f36ca12f9486916e59e926773e166672d 8da0577d-17b6-11ed-b6b8-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=17308 http://tlcr.amegroups.com/article/view/40413/pdf 1 https://dirros.openscience.si/Dokument.php?lang=slv&id=14983 Univerzitetna klinika za pljučne bolezni in alergijo Golnik 0 0 0